TickerFactsScreenerDevelopers

Vir Biotechnology, Inc. (VIR) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2017: $187.92M2018: $47.60M2019: $109.33M2020: $436.57M2021: $347.81M2022: $848.63M2023: $241.58M2024: $222.95M2025: $232.19M$232.19M
2017Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$232.19M+4.1%
2024$222.95M-7.7%
2023$241.58M-71.5%
2022$848.63M+144.0%
2021$347.81M-20.3%
2020$436.57M+299.3%
2019$109.33M+129.7%
2018$47.60M-74.7%
2017$187.92M—